AN ACT to amend and reenact subsections 7 and 18 of section 19-24.1-01, and subdivision c of subsection 2 of section 19-24.1-03 of the North Dakota Century Code, relating to medical marijuana container sizes, caregivers, and documentation.
SB2293 makes targeted changes to North Dakota’s medical marijuana law. It revises the definition of “cannabinoid concentrate” to specify that a dispensing container for concentrate may not exceed one gram, and it updates the definition of “designated caregiver” to require the caregiver to be at least 21 years old and to manage the well-being of a registered qualifying patient in connection with the patient’s medical marijuana use.
The bill also changes the documentation required for an original qualifying patient application for a registry identification card. It keeps the core application items—name, address, date of birth, caregiver information if applicable, signature, and federal firearm warning—but adds flexibility for applicants who cannot obtain a current North Dakota ID because of a medical condition by allowing other department-approved documentation. For minors, it continues to require a certified birth record or a photographic copy of a North Dakota ID, and it preserves the requirement for a parent or legal guardian signature.
If enacted, SB2293 would amend sections of the North Dakota Century Code governing the medical marijuana registry and patient access process. The practical effect is to tighten the dispensing limit for cannabinoid concentrates, clarify caregiver eligibility, and broaden acceptable identity documentation for certain applicants, especially those whose medical condition prevents them from obtaining standard identification. These changes affect patients, caregivers, dispensaries, and the Department of Health or other administering agency responsible for registry cards and verification.
The bill appears to have received generally favorable support in both chambers, passing the Senate 41-3 and the House 62-22. The vote margins suggest broad acceptance of the bill’s administrative and regulatory adjustments, though the House vote indicates more substantial opposition than the Senate. No committee transcript is available, so the record does not show detailed debate, but the final votes indicate the bill was viewed as a modest, policy-specific update rather than a major overhaul of the medical marijuana program.
The main points of possible contention are the one-gram cap on cannabinoid concentrate containers, which may be seen as restrictive by some medical marijuana patients or providers, and the caregiver age requirement, which could limit who may serve in that role. The documentation provisions may also have drawn attention because they balance access for medically impaired applicants against identification and verification requirements. The recorded opposition in the House suggests some lawmakers may have objected to one or more of these regulatory limits, even though the bill ultimately passed comfortably.